White Matter Correlates of Apathy in HIV-Positive Subjects: A Diffusion Tensor Imaging Study
2010; American Psychiatric Association Publishing; Volume: 22; Issue: 3 Linguagem: Inglês
10.1176/jnp.2010.22.3.313
ISSN1545-7222
AutoresJacqueline Hoare, Jean‐Paul Fouché, Bruce Spottiswoode, John A. Joska, Renata Schoeman, Dan J. Stein, Paul D. Carey,
Tópico(s)Neurological and metabolic disorders
ResumoBack to table of contents Previous article Next article REGULARFull AccessWhite Matter Correlates of Apathy in HIV-Positive Subjects: A Diffusion Tensor Imaging StudyJacqueline Hoare M.B.Ch.B., M.R.C.Psych., F.C.Psych.Jean-Paul Fouche Bsc., HonsBsc.Bruce Spottiswoode Ph.D.John A. Joska M.B.Ch.B., M.Med., F.C.Psych.Renata Schoeman M.B.Ch.B., M.Soc.Sc., F.C.Psych., M.Med.Dan J. Stein F.C.Psych., Ph.D.Paul D. Carey F.C.Psych., Ph.D.Jacqueline Hoare M.B.Ch.B., M.R.C.Psych., F.C.Psych.Search for more papers by this authorJean-Paul Fouche Bsc., HonsBsc.Search for more papers by this authorBruce Spottiswoode Ph.D.Search for more papers by this authorJohn A. Joska M.B.Ch.B., M.Med., F.C.Psych.Search for more papers by this authorRenata Schoeman M.B.Ch.B., M.Soc.Sc., F.C.Psych., M.Med.Search for more papers by this authorDan J. Stein F.C.Psych., Ph.D.Search for more papers by this authorPaul D. Carey F.C.Psych., Ph.D.Search for more papers by this authorPublished Online:1 Jul 2010AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail D espite the introduction of highly active antiretroviral treatment (HAART), individuals infected with HIV frequently exhibit neuropsychiatric symptoms including the more severe HIV-associated dementia; a less symptomatic, but significantly impairing, mild neurocognitive disorder 1 , 2 ; and apathy. Apathy or decreased motivation in HIV can affect performance on nearly all aspects of cognitive, instrumental, and interpersonal functions. 3 It is unclear whether apathy in HIV patients reflects a direct effect of the virus on subcortical brain regions or a secondary neuropsychiatric symptom. We investigate whether apathy in the absence of cognitive decline and depression results from damage to white matter using diffusion tensor imaging (DTI). While HAART is effective in many who will develop neurocognitive disorders in HIV, 4 evidence suggests that many will develop these disorders earlier than current treatment regimes would sanction initiation of treatment. 5 It is also not known in the earlier phases of the disease who will go on to develop neurocognitive disorders, nor who will respond to treatment. 6 The neurotoxic effects of HIV result in damage to white matter tracts in the brain. 7 Once damage is established and related cognitive disorders ensue, the ability of HAART to reverse existing dysfunction is probably limited. 8 Earlier treatment with HAART in at-risk or minimally symptomatic patients may prevent further decline in cognition and delay the course of HIV disease. Identification of reliable early behavioral and imaging correlates of risk for subsequent cognitive dysfunction, such as apathy, become all the more crucial to delineate. Apathy refers to reduced self-initiated cognitive, emotional, and behavioral activity. 9 Apathy has been recognized as a potential early behavioral feature of HIV-associated dementia. 10 , 11 It occurs along with other symptoms of subcortical dysfunction including memory impairment, poor concentration, and reduced psychomotor speed. 12 Apathy has also been reported to be prevalent in HIV patients without dementia, 13 and as such may not be confined to late-stage disease (i.e., people with CD4 cell counts 10) and be free of psychotropic medication and have had no recent (within 6 months) substance abuse history. The presence of other current DSM-IV disorders, determined through semistructured interviews using the Mini-International Neuropsychiatric Interview, 22 was also an exclusion criterion. HIV diagnosis was based on serologic testing by ELISA and Western blot. Patients were excluded if they reported a history of head injury with loss of consciousness exceeding 10 minutes. ProcedureParticipants completed clinical assessments in a single testing session. Neuroimaging was conducted within 1 week of the initial evaluation. All measures were administered and scored according to standard procedures. Written informed consent was obtained prior to enrollment and exposure to any study-related procedure. The protocol was approved in writing by the Committee for Human Research of the University of Stellenbosch.Apathy Apathy was measured using the clinician-rated Apathy Evaluation Scale. The Apathy Evaluation Scale is comprised of 18 items that relate to motivation, self-initiation, and drive and has sound psychometric properties. 23 Participants are asked to register their degree of agreement with each question using a four-point Likert scale. Higher scores reflect greater apathy (1=not at all, 4=extremely). Excluding significant mood symptoms even though subjects did not meet criteria for a major depressive disorder was important to ensure careful distinction of potentially overlapping symptoms of depression and apathy. We used the 14-item clinician-rated Hamilton Depression Rating Scale (HAM-D) 24 which has been shown to reliably differentiate depressed from nondepressed subjects with HIV. 25 It has also been widely used in treatment studies of depression in HIV. A HAM-D score of 16 (moderate depression) was taken as a cutoff for significant depressive symptoms and served as an additional exclusion from the cohorts. To screen for the presence of HANDs, we used the well-validated International HIV Dementia Scale, 26 a brief and reliable measure of global cognitive function that is reliably able to identify features of HIV-associated dementia. A neuropsychological test battery was administered to all participants to assess specific domains of attention, concentration, learning, memory, psychomotor speed, and executive function. We used the major components of the MATRICS Consensus Cognition Battery. 27 , 28 Speed of processing was assessed with the symbol coding test (digit-symbol matching) and the Trail Making test, part A. 29 Attention and vigilance were assessed by a computerized version of the continuous performance test. We examined working memory using the Weschler Memory Scale for Nonverbal Memory (spatial span test) and the letter/number span test for verbal memory. 29 For verbal learning, the Hopkins Verbal Learning Test—Revised was used, 30 and animal naming for category/verbal fluency. Visual learning and visuospacial function were examined using the Visual Special Memory Test (revised edition). For reasoning and problem solving (planning and reasoning ability), we used neuropsychology assessment battery (NAB) mazes. A full neuromedical examination was conducted on all participants. Blood for CD4 cell counts and HIV RNA load (20 ml) were taken in the infectious diseases clinic. Urine for screening of illicit drug use was taken at screening.Brain Imaging Imaging was performed at The Cape Universities Brain Imaging Centre (CUBIC) on a Siemens Magnetom 3T Allegra within 7 days of the screening and neuropsychological assessment. We acquired a multidirectional diffusion weighted sequence with 30 diffusion directions, 1 b=0 sec/mm 2 direction, TR=8,800 msec, TE=88 msec, and a b-value=1,000 sec/mm 2 . The images were acquired as a mosaic resulting in a 960×960 matrix with 60 slices per volume and a corresponding in-plane spatial resolution and slice thickness of 2×2 mm 2 and 2.2 mm, respectively. The 2.30 minute sequence was repeated three times and averages were derived. Image ProcessingPreprocessing of the images was conducted in FMRIB Software Library and MATLAB respectively. First the images underwent eddy current correction in FSL. The tensor residuals for each pixel in the images were then computed and any outliers were removed, resulting in an average DTI and fractional anisotropy map for each subject. An affine as well as a nonlinear registration of the B0 images to each subject’s structural T1 image (intra-subject) was performed. The warps were applied to the fractional anisotropy images. A mean fractional anisotropy template was then created from all the subjects, followed by a final registration and warp of all the fractional anisotropy images to the mean template. A general linear model ANOVA was performed on the fractional anisotropy voxels of each cohort to determine significant differences between the groups. This was performed at a p<0.05 uncorrected threshold with a fractional anisotropy mask of 0.25.Contrasts between HIV+ groups were then drawn to examine the associations between apathy, performance on neuropsychological tests, and white matter fractional anisotropy. As apathy was not normally distributed among either patient group, nonparametric statistics were conducted for all analyses in which apathy was included.RESULTS Of the 40 subjects originally enrolled, 36 participants (HIV+ with apathy, n=13; HIV+ without apathy, n=13; healthy comparison subjects, n=10) were included in the final analysis. Two imaging sequences in each of the HIV+ groups were discarded due to movement artifacts (n=3) and poor quality acquisition (n=1). The mean ages of the apathetic and nonapathetic cohorts were 33.08 years old (SD=3.9) and 34.23 years old (SD=4.3), respectively, which is similar to the average age of presentation with Stage III HIV disease in our adult infectious diseases population. HIV+ participants had been on antiretroviral drugs for a minimum of 3 months. Together, low viral loads and being clinically asymptomatic suggest that HAART is largely effective in this cohort ( Table 1 ). At 22.6 years old (SD=5.2), the average age of the HIV− comparison cohort was younger than either of the HIV+ cohorts, but they were similar with respect to years of education (mean=10 years). TABLE 1. Demographic and Clinical Characteristics of SampleTABLE 1. Demographic and Clinical Characteristics of SampleEnlarge table Apathy Evaluation Scale scores in the HIV+ apathetic group (46.00, SD=6.0) were higher than those of HIV+ nonapathetic participants (30.46, SD=5.9) and healthy comparison subjects (24.2, SD=4.5). Depression scores were similar across groups ( Table 1 ). In the first contrast of HIV+ nonapathetic participants versus HIV+ patients with apathy, HIV+ nonapathetic participants demonstrated significantly higher fractional anisotropy values in the genu of the corpus callosum (p=0.002), the superior corona radiata (p=0.0009), and anterior corona radiata (p=0.0002), and the anterior thalamic radiation (p=0.0002) ( Table 3 ; Figure 1 , Figure 2 , and Figure 3 ). TABLE 3. Voxel-Based Analysis Contrasts of Fractional Anisotropy ValuesTABLE 3. Voxel-Based Analysis Contrasts of Fractional Anisotropy ValuesEnlarge tableFIGURE 1. MATLAB DTI In-House Analysis Uncorrected p<0.05Anatomy: genu of the corpus callosum (bilateral). ROI p value: p=0.002FIGURE 2. MATLAB DTI In-House Analysis Uncorrected p<0.05Anatomy: superior corona radiata, right side. ROI p value: p=0.0009FIGURE 3. MATLAB DTI In-House Analysis Uncorrected p<0.05ROI p value: p=0.00017. Anatomy: anterior corona radiata extending to anterior thalamic radiation (left side) We also examined the contrasts of healthy comparison subjects versus HIV+ nonapathetic participants. The healthy comparison subjects had significantly higher fractional anisotropy values in the corticospinal tract (p=0.016), the body of the corpus callosum (p=0.039), the anterior thalamic radiation (p=0.011), the superior longitudinal fasciculus (p=0.00017), the superior corona radiata (p=0.012), and the genu of the corpus callosum (p=0.0024) ( Table 3 ). Regression analyses with fractional anisotropy values as the dependent variable and individual neuropsychological tests scores as independent variables found a significant effect of the Hopkins Verbal Learning Test and mean fractional anisotropy in the superior corona radiata (R=0.613, p=0,039). No other brain region fractional anisotropy was associated with neuropsychological function in any of the cognitive domains tested. Apathy scores and fractional anisotropy values were negatively correlated in the sagittal stratum, posterior corona radiata, genu of the corpus callosum, superior corona radiata, corticopontine/corticospinal tract, and corticopontine/anteriorthalamic radiation ( Table 2 ) . TABLE 2. Scores for Neuropsychology Battery for HIV+ Apathy and Nonapathy GroupsTABLE 2. Scores for Neuropsychology Battery for HIV+ Apathy and Nonapathy GroupsEnlarge table Shown in Figure 1 , Figure 2 , and Figure 3 is the ANOVA voxel-based analysis of the DTI images. The images are shown in the axial, sagittal, and coronal fields, respectively, with the R indicating the right hemisphere. The region of interest is indicated with the crosshairs, and the graph in the lower right corner shows the different subjects in relation to one another. The HIV+ nonapathy group is on the right side of the graph and the HIV+ apathy group is on the left. Each circle represents one subject with n=13 for both groups. The p value shown on the graph is only for the specific point in the cluster; included is the centroid p value for each cluster as well. HIV+ Nonapathy (n=13) Versus HIV+ Apathy (n=13)Figure 1 , Figure 2 , and Figure 3 show the decreases in fractional anisotropy (gray) for the HIV+ apathy cohort when compared to the HIV+ nonapathy cohort. DISCUSSIONThe main findings in our study were first that apathy as measured by the Apathy Evaluation Scale was present in a cohort of HIV+ patients in the absence of depression and cognitive impairment. A second DTI revealed lower fractional anisotropy in both the HIV+ groups in the corpus callosum. These were significantly lower in the apathy group, giving a strong indication that this medial brain region is differentially affected by apathy in HIV disease. This suggests that white matter damage is consequent to HIV-mediated neurotoxicity and that in some patients, this damage is clinically expressed as apathy in the absence of a wider or at least symptomatic cognitive disorder. Higher scores of apathy correlated significantly with lower fractional anisotropy values when contrasted with subjects who were HIV+ but were not apathetic. Consistent with recent studies, 13 we found elevated rates of apathy in patients without dementia and depression. Tate et al. 14 reported that apathy is present even among patients without severe immune suppression. Although symptoms of apathy also overlap with features of depression, the two conditions are unique and have been reliably differentiated in patient samples. 9 HIV has an affinity for 31 the basal ganglia which are critical nuclei in parallel frontal subcortical circuits. These circuits regulate cognition, emotions, and behavioral activation. 32 It is therefore not surprising that apathy and depression are both observed, concurrently and independently, in a substantial percentage of HIV-infected patients. 33 Our contrasts of healthy comparison subjects versus HIV+ nonapathetic participants showed HIV-mediated damage to white matter. Healthy comparison subjects had significantly higher fractional anisotropy values in the corpus callosum, the anterior thalamic radiation, the superior longitudinal fasciculus, and the superior corona radiata. Diffusion tensor abnormalities involving the frontal white matter and the corpus callosum have been observed in patients infected with HIV. 19 These include findings of callosal white matter thinning in cognitively asymptomatic patients infected with HIV. 31 The corpus callosum is central to interhemispheric relay and integration, as well as providing a link with subcortical structures, such as the basal ganglia. 34 Injury may be reflected in slowed response initiation and longer reaction times on tasks involving hemispheric transfer or integration between regions. 34 Studies of other CNS disorders characterized by cognitive decline have found evidence that DTI measurements acquired in the corpus callosum may be sensitive to subtle or early changes not apparent on conventional images. 35 This is likely attributable to the lower fractional anisotropy measurement error in regions, such as the corpus callosum, which have intrinsically high anisotropy. 36 Results of the present study contrasting HIV+ nonapathetic participants with HIV+ patients with apathy confirm our hypothesis in which we anticipated changes associated with apathy in white matter tracts that relay through the medial prefrontal cortex including the corpus callosum, the anterior thalamic radiation, and the corona radiata. These findings provide evidence that the behavioral phenotype of apathy is associated with neural changes induced by HIV. These results contrast with those of voxel-based morphometry in which we examined regional tissue type differences in volume across the brain and found no statistical differences in brain volumes between HIV+ groups (Moodliar et al., unpublished data, April 2009). Our findings here are consistent with current neuroanatomical models which emphasize the role of medial and dorsolateral prefrontal cortex including the anterior cingulate cortex in the initiation and execution of complex tasks, 37 for behavioral drive and dysfunction being seen as the apathetic behavioral syndrome. 38 , 39Limitations of our study include the absence of full neuropsychological assessments in our healthy comparison subjects. We do, however, have data on years of education, making it reasonable to assume that they had normal neuropsychological function overall. Our sample size is small, and our data are cross-sectional and as such are not able to address the question of whether apathy represents an early marker of subsequent cognitive decline.Despite these limitations, findings here revealed lower fractional anisotropy in both HIV+ groups in the corpus callosum; these were significantly lower in the apathetic group, giving a strong indication that this medial brain region is differentially affected by apathy in HIV disease. Future work could usefully focus on anisotropy measurements of the corpus callosum as a quantitative imaging biomarker in the setting of HANDs using larger longitudinal studies. Studies examining response to HAART treatment in patients infected with HIV will be important to determine whether DTI abnormalities observed in the corpus callosum and other regions reflect reversible or more advanced irreversible injury. Additional work is needed to examine the clinical and functional relevance of white matter disconnectivity and neuropsychiatric symptoms such as apathy in HIV in greater detail. Correlates of white matter damage and neurocognitive decline need to be sought, including whether measures of central viral load correlate with poor fractional anisotropy values, illness duration, age, treatment exposure and treatment adherence. These factors are almost certainly critical in determining the overall impact of HIV on brain function, and in particular on white matter integrity.Received July 1, 2009; revised August 14, 2009; accepted August 31, 2009. Drs. Hoare, Schoeman, and Carey are affiliated with the Department of Psychiatry Stellenbosch University in Stellenbosch, South Africa; Drs. Fouche, Stein, and Carey are affiliated with the MRC Research Unit on Anxiety Disorders, Department of Psychiatry, Stellenbosch University; Dr. Spottiswoode is affiliated with the MRC Medical Imaging Unit, University of Cape Town, and with the Department of Radiological Sciences and Oncology, Stellenbosch University; Drs. Hoare, Joska, and Stein are affiliated with the Department of Psychiatry and Mental Health, University of Cape Town. Address correspondence to Jacqueline Hoare, Department of Psychiatry and Mental Health, University of Cape Town, Anzio Road Observatory, 7925, Cape Town, South Africa; [email protected] (e-mail).Copyright © 2010 American Psychiatric Publishing, Inc.References1. Sacktor N, McDermott MP, Marder K, et al: HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002; 8:136–142Google Scholar2. Schifitto G, McDermott MP, McArthur JC, et al: Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 2002; 58:1764–1768Google Scholar3. Cummings JL, Mega MS: Neuropsychiatry and Behavioral Neuroscience. New York, Oxford University Press, 2003Google Scholar4. Chang L, Ernst T, Leonido-Yee M, et al: Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 1999; 53:782–789Google Scholar5. Ernst T, Chang L, Jovicich J, et al: Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology 2002; 59:1343–1349Google Scholar6. Tozzi V, Balestra P, Galgani S, et al: Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS 1999; 13:1889–1897Google Scholar7. Langford TD, Letendre SL, Larrea GJ, et al: Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol 2003; 13:195–210Google Scholar8. Nath A, Schiess N, Venkatesan A, et al: Evolution of HIV Dementia with HIV infection. Baltimore, Md, Department of Neurology, Johns Hopkins University, 2007Google Scholar9. Marin RS: Differential diagnosis and classification of apathy. Am J Psychiatry 1990; 147:22–30Google Scholar10. Paul RH, Brickman AM, Navia B, et al: Apathy is associated with volume of the nucleus accumbens in patients infected with HIV. J Neuropsychiatry Clin Neurosci 2005; 17:167–171Google Scholar11. Paul R, Flanigan TP, Tashima K, et al: Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus. J Neuropsychiatry Clin Neurosci 2005; 17:114–118Google Scholar12. Ho DD, Bredesen DE, Vinters HV, et al: The acquired immunodeficiency syndrome (AIDS) dementia complex. Ann Intern Med 1989; 111:400–410Google Scholar13. Castellon SA, Hinkin CH, Myers HF: Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection. J Int Neuropsychol Soc 2000; 6:336–347Google Scholar14. Tate D, Paul R, Flanigan T, et al: Impact of apathy on quality of life in HIV. AIDS Patient Care 2003; 17:115–120Google Scholar15. Starkstein SE, Mayberg HS, Preziosi TJ, et al: Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 1992; 4:134–139Google Scholar16. Ott BR, Noto RB, Fogel BS: Apathy and loss of insight in Alzheimer’s disease: a SPECT imaging study. J Neuropsychiatry Clin Neurosci 1996; 8:41–46Google Scholar17. Basser PJ: Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed 1995; 8:333–344Google Scholar18. Gray F, Scaravilli F, Everall I, et al: Neuropathology of early HIV-1 infection. Brain Pathol 1996; 6:1–15Google Scholar19. Pomara N, Crandall DT, Choi SJ, et al: White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res 2001; 106:15–24Google Scholar20. Thurner MM, Castillo M, Stadler A, et al: Diffusion-tensor imaging of the brain in human immunodeficiency virus-positive patients. AJNR Am J Neuroradiol 2005; 26:2275–2281Google Scholar21. Wu Y, Storey P, Cohen BA, et al: Diffusion alterations in corpus callosum of patients with HIV. AJNR Am J Neuroradiol 2006; 27:656–660Google Scholar22. Sheehan DV, Lecrubier Y, Sheehan KH, et al: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structures diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59:22–33Google Scholar23. Marin RS, Biedrzycki RC, Firinciogullari S: Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 1991; 38:143–162Google Scholar24. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56–62Google Scholar25. Cockram A, Judd FK, Mijch A, et al: The evaluation of depression in inpatients with HIV disease. Aust N Z J Psychiatry 1999; 33:344–352Google Scholar26. Sacktor NC, Wong M, Nakasujja N, et al: The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 2005; 19:1367–1374Google Scholar27. Kern RS, Nuechterlein KH, Green MF, et al: The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry 2008; 165:214–220Google Scholar28. Nuechterlein KH, Green MF, Kern RS, et al: The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry 2008; 165:203–213Google Scholar29. Weschler D: Weschler Memory Scale—Revised. San Antonio, Tex, Psychological Corp, 1987Google Scholar30. Woods SP, Scott JC, Dawson MS, et al: Construct validity of Hopkins Verbal Learning Test—Revised component process measures in an HIV-1 sample. Arch Clin Neuropsychol 2005; 20:1061–1071Google Scholar31. Aylward E, Henderer B, McArthur J, et al: Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 1993; 43:2099–2104Google Scholar32. Tekin S, Cummings JL: Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002; 53:647–654Google Scholar33. McArthur J: Neurological and neuropathological manifestations of HIV infection, in Neuropsychology of HIV Infection. Edited by Grant I, Martin A. New York, Oxford University Press, 1994, pp 56–107Google Scholar34. Reuter-Lorenz PA: Parallel processing in the bisected brain: implications for callosal function, in The Parallel Brain. Edited by Zaidel E, Iacoboni M. Cambridge, Mass, MIT Press, 2003, pp 341–354Google Scholar35. Bozzali M, Falini A, Franceschi M, et al: White matter damage in Alzheimer’s disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2002; 72:742–746Google Scholar36. Pierpaoli C, Basser PJ: Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 1996; 36:893–906Google Scholar37. Cummings JL: Anatomic and behavioral aspects of frontal-subcortical circuits. Ann N Y Acad Sci 1995; 769:1–13Google Scholar38. Alexander GE, Crutcher MD: Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990; 13:266–271Google Scholar39. Andersson S, Bergedalen AM: Cognitive correlates of apathy in traumatic brain injury. Neuropsychiatry Neuropsychol Behav Neurol 2002; 15:184–191Google Scholar FiguresReferencesCited byDetailsCited byApathy in persons living with HIV disease: A systematic narrative reviewJournal of Affective Disorders, Vol. 350Elevated Plasma Protein Carbonyl Concentration Is Associated with More Abnormal White Matter in People with HIV12 December 2023 | Viruses, Vol. 15, No. 12Update on Central Nervous System Effects of HIV in Adolescents and Young Adults21 February 2023 | Current HIV/AIDS Reports, Vol. 13Altered white matter integrity in the corpus callosum in adults with HIV: a systematic review of diffusion tensor imaging studiesPsychiatry Research: Neuroimaging, Vol. 326HIV‐induced neuroinflammation inhibits oligodendrocyte maturation via glutamate‐dependent activation of the PERK arm of the integrated stress response31 May 2021 | Glia, Vol. 69, No. 9Magnetisation transfer imaging revealed microstructural changes related to apathy symptoms after ischaemic stroke26 February 2021 | International Journal of Geriatric Psychiatry, Vol. 36, No. 8Apathy is Associated with Critical Psychological Determinants of Medication Adherence in HIV Disease6 April 2020 | Journal of Clinical Psychology in Medical Settings, Vol. 28, No. 2Protease Inhibitors, Saquinavir and Darunavir, Inhibit Oligodendrocyte Maturation: Implications for Lysosomal Stress28 November 2019 | Journal of Neuroimmune Pharmacology, Vol. 16, No. 1Widespread white matter aberration is associated with the severity of apathy in amnestic Mild Cognitive Impairment: Tract-based spatial statistics analysisNeuroImage: Clinical, Vol. 29HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History12 June 2020 | Journal of Neuroimmune Pharmacology, Vol. 15, No. 4Mental Health and Functional Competence in the Cape Town Adolescent Antiretroviral CohortJAIDS Journal of Acquired Immune Deficiency Syndromes, Vol. 81, No. 4Different roles of frontal versus striatal atrophy in HIV‐associated neurocognitive disorders28 March 2019 | Human Brain Mapping, Vol. 40, No. 10Interferon‐free therapy as the cause of white matter tracts and cerebral perfusion recovery in patients with chronic hepatitis C27 February 2019 | Journal of Viral Hepatitis, Vol. 26, No. 6, Vol. 165Brain Research, Vol. 1724Structural brain changes in perinatally HIV-infected young adolescents in South AfricaAIDS, Vol. 32, No. 18Systematic review with meta‐analysis: neuroimaging in hepatitis C chronic infection14 March 2018 | Alimentary Pharmacology & Therapeutics, Vol. 47, No. 9, Vol. 152Neuropsychologia, Vol. 118Journal of Clinical and Experimental Neuropsychology, Vol. 40, No. 4Psychiatric Comorbidities in HIV Infection28 September 2017White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatmentAIDS, Vol. 30, No. 2Depression and Apathy Among People Living with HIV: Implications for Treatment of HIV Associated Neurocognitive Disorders23 December 2014 | AIDS and Behavior, Vol. 19, No. 8Psychiatric Assessment of Liver Transplant CandidatesBrain, Behavior, and Immunity, Vol. 45Journal of Affective Disorders, Vol. 175Neuroscience & Biobehavioral Reviews, Vol. 55Neural correlates of apathy revealed by lesion mapping in participants with traumatic brain injuries13 February 2013 | Human Brain Mapping, Vol. 35, No. 3Symptoms of common mental disorder and cognitive associations with seropositivity among a cohort of people coming for testing for HIV/AIDS in Goa, India: a cross-sectional survey7 March 2013 | BMC Public Health, Vol. 13, No. 1Journal of Affective Disorders, Vol. 150, No. 3Journal of Hepatology, Vol. 59, No. 4PLoS ONE, Vol. 8, No. 1Elevated Neurobehavioral Symptoms Are Associated With Everyday Functioning Problems in Chronic Methamphetamine UsersJordan E. Cattie, B.S., Steven Paul Woods, Psy.D., Jennifer E. Iudicello, Ph.D., Carolina Posada, M.S., Igor Grant, M.D., and 1 July 2012 | The Journal of Neuropsychiatry and Clinical Neurosciences, Vol. 24, No. 3Current World LiteratureCurrent Opinion in Neurology, Vol. 24, No. 3Current HIV/AIDS Reports, Vol. 8, No. 1Journal of NeuroVirology, Vol. 17, No. 1 Volume 22Issue 3 Summer, 2010Pages 313-320 Metrics PDF download History Published online 1 July 2010 Published in print 1 July 2010
Referência(s)